Cardiovascular effects of romifidine in dogs

Bruno H. Pypendop Department of Small Animal Clinical Sciences, Section of Small Animal Reproduction, School of Veterinary Medicine, University of Liege, Bd de Colonster, 20, B44, Sart Tilman, B4000 Liege, Belgium.
Veterinary Medical Teaching Hospital, School of Veterinary Medicine, University of California, Davis, CA 95616.

Search for other papers by Bruno H. Pypendop in
Current site
Google Scholar
PubMed
Close
 DVM, PhD
and
John P. Verstegen Department of Small Animal Clinical Sciences, Section of Small Animal Reproduction, School of Veterinary Medicine, University of Liege, Bd de Colonster, 20, B44, Sart Tilman, B4000 Liege, Belgium.

Search for other papers by John P. Verstegen in
Current site
Google Scholar
PubMed
Close
 DVM, PhD

Abstract

Objective—To characterize the cardiovascular effects of romifidine at doses ranging from 5 to 100 µg/kg of body weight, IV.

Animals—25 clinically normal male Beagles.

Procedure—Romifidine was administered IV at a dose of 5, 10, 25, 50, or 100 µg/kg (n = 5/group). Heart rate, arterial pressure, central venous pressure, mean pulmonary arterial pressure, pulmonary capillary wedge pressure, body temperature, cardiac output, and PCV were measured immediately prior to and at selected times after romifidine administration. Cardiac index, stroke index, rate-pressure product, systemic and pulmonary vascular resistance indices, and left and right ventricular stroke work indices were calculated. Degree of sedation was assessed by an observer who was blinded to the dose administered.

Results—Romifidine induced a decrease in heart rate, pulmonary arterial pressure, rate-pressure product, cardiac index, and right ventricular stroke work index and an increase in central venous pressure, pulmonary capillary wedge pressure, and systemic vascular resistance index. In dogs given romifidine at a dose of 25, 50, or 100 µg/kg, an initial increase followed by a prolonged decrease in arterial pressure was observed. Arterial pressure immediately decreased in dogs given romifidine at a dose of 5 or 10 µg/kg.

Conclusion and Clinical Relevance—Results suggest that IV administration of romifidine induces dose-dependent cardiovascular changes in dogs. However, the 2 lowest doses (5 and 10 µg/kg) induced less cardiovascular depression, and doses ≥ 25 µg/kg induced similar cardiovascular changes, suggesting that there may be a ceiling on the cardiovascular effects of romifidine. (Am J Vet Res 2001; 62:490–495)

Abstract

Objective—To characterize the cardiovascular effects of romifidine at doses ranging from 5 to 100 µg/kg of body weight, IV.

Animals—25 clinically normal male Beagles.

Procedure—Romifidine was administered IV at a dose of 5, 10, 25, 50, or 100 µg/kg (n = 5/group). Heart rate, arterial pressure, central venous pressure, mean pulmonary arterial pressure, pulmonary capillary wedge pressure, body temperature, cardiac output, and PCV were measured immediately prior to and at selected times after romifidine administration. Cardiac index, stroke index, rate-pressure product, systemic and pulmonary vascular resistance indices, and left and right ventricular stroke work indices were calculated. Degree of sedation was assessed by an observer who was blinded to the dose administered.

Results—Romifidine induced a decrease in heart rate, pulmonary arterial pressure, rate-pressure product, cardiac index, and right ventricular stroke work index and an increase in central venous pressure, pulmonary capillary wedge pressure, and systemic vascular resistance index. In dogs given romifidine at a dose of 25, 50, or 100 µg/kg, an initial increase followed by a prolonged decrease in arterial pressure was observed. Arterial pressure immediately decreased in dogs given romifidine at a dose of 5 or 10 µg/kg.

Conclusion and Clinical Relevance—Results suggest that IV administration of romifidine induces dose-dependent cardiovascular changes in dogs. However, the 2 lowest doses (5 and 10 µg/kg) induced less cardiovascular depression, and doses ≥ 25 µg/kg induced similar cardiovascular changes, suggesting that there may be a ceiling on the cardiovascular effects of romifidine. (Am J Vet Res 2001; 62:490–495)

All Time Past Year Past 30 Days
Abstract Views 37 0 0
Full Text Views 1615 1475 503
PDF Downloads 126 73 2
Advertisement